Analysts See $-0.09 EPS for Idera Pharmaceuticals, Inc. (IDRA); Aureus Asset Management Has Lifted By $537,927 Its Apple (AAPL) Stake

April 13, 2018 - By Richard Conner

Apple Inc. (NASDAQ:AAPL) Logo

Analysts expect Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) to report $-0.09 EPS on May, 3.They anticipate $0.01 EPS change or 10.00% from last quarter’s $-0.1 EPS. After having $-0.08 EPS previously, Idera Pharmaceuticals, Inc.’s analysts see 12.50% EPS growth. The stock increased 0.56% or $0.01 during the last trading session, reaching $1.8. About 351,555 shares traded. Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) has declined 21.96% since April 13, 2017 and is downtrending. It has underperformed by 33.51% the S&P500.

Aureus Asset Management Llc increased Apple Inc. (AAPL) stake by 3.33% reported in 2017Q4 SEC filing. Aureus Asset Management Llc acquired 3,183 shares as Apple Inc. (AAPL)’s stock declined 3.81%. The Aureus Asset Management Llc holds 98,836 shares with $16.73 million value, up from 95,653 last quarter. Apple Inc. now has $884.60B valuation. The stock increased 0.11% or $0.2 during the last trading session, reaching $174.34. About 8.23M shares traded. Apple Inc. (NASDAQ:AAPL) has risen 19.49% since April 13, 2017 and is uptrending. It has outperformed by 7.94% the S&P500.

Aureus Asset Management Llc decreased W. R. Grace & Co. (NYSE:GRA) stake by 16,239 shares to 159,097 valued at $11.16 million in 2017Q4. It also reduced Constellation Brands Inc. Class A (NYSE:STZ) stake by 2,380 shares and now owns 100,002 shares. Svb Financial Group (NASDAQ:SIVB) was reduced too.

Investors sentiment increased to 0.73 in Q4 2017. Its up 0.03, from 0.7 in 2017Q3. It increased, as 50 investors sold AAPL shares while 1023 reduced holdings. 151 funds opened positions while 637 raised stakes. 2.98 billion shares or 0.18% more from 2.97 billion shares in 2017Q3 were reported. Old Mutual Customised Solutions (Proprietary) Limited holds 1.4% or 80,766 shares in its portfolio. Greenwich Wealth Management Ltd Limited Liability Company, Connecticut-based fund reported 65,036 shares. Menlo Advisors reported 3.02% in Apple Inc. (NASDAQ:AAPL). Newman Dignan Sheerar has invested 1.85% in Apple Inc. (NASDAQ:AAPL). Dorsey Whitney Tru Llc stated it has 1.14% of its portfolio in Apple Inc. (NASDAQ:AAPL). Barrett Asset Management Lc holds 221,523 shares or 2.64% of its portfolio. Wealthtrust holds 10,717 shares or 0.89% of its portfolio. Westchester Capital Inc holds 5.56% or 79,855 shares in its portfolio. Cs Mckee LP has invested 3.82% in Apple Inc. (NASDAQ:AAPL). Iconiq Capital Limited Liability Corp owns 30,480 shares for 0.53% of their portfolio. Peninsula Asset Inc holds 15,918 shares. First Pacific Advisors Limited Co reported 13,700 shares. Sage Group has invested 0.01% in Apple Inc. (NASDAQ:AAPL). Boston Common Asset Mgmt Ltd Limited Liability Company holds 3.55% of its portfolio in Apple Inc. (NASDAQ:AAPL) for 176,915 shares. 85,594 were reported by Wilsey Asset.

Among 53 analysts covering Apple Inc. (NASDAQ:AAPL), 34 have Buy rating, 1 Sell and 18 Hold. Therefore 64% are positive. Apple Inc. had 392 analyst reports since July 21, 2015 according to SRatingsIntel. On Wednesday, August 2 the stock rating was maintained by BMO Capital Markets with “Outperform”. Morgan Stanley maintained Apple Inc. (NASDAQ:AAPL) rating on Tuesday, February 21. Morgan Stanley has “Overweight” rating and $154 target. The rating was maintained by J.P. Morgan on Wednesday, August 2 with “Buy”. The company was maintained on Tuesday, March 21 by Bernstein. On Monday, December 4 the stock rating was maintained by Tigress Financial with “Buy”. The stock of Apple Inc. (NASDAQ:AAPL) has “Buy” rating given on Wednesday, October 26 by Goldman Sachs. Hilliard Lyons upgraded Apple Inc. (NASDAQ:AAPL) on Monday, February 5 to “Buy” rating. The company was maintained on Monday, June 26 by RBC Capital Markets. The stock of Apple Inc. (NASDAQ:AAPL) has “Buy” rating given on Wednesday, October 28 by Stifel Nicolaus. As per Tuesday, August 11, the company rating was maintained by Oppenheimer.

Since December 7, 2017, it had 0 insider buys, and 4 insider sales for $19.89 million activity. SCHILLER PHILIP W sold $11.56M worth of Apple Inc. (NASDAQ:AAPL) on Tuesday, April 3. On Friday, January 5 Riccio Daniel J. sold $2.73M worth of Apple Inc. (NASDAQ:AAPL) or 15,641 shares.

Since October 26, 2017, it had 1 insider buy, and 2 sales for $7.00 million activity. On Thursday, October 26 the insider BAKER BROS. ADVISORS LP bought $12.00M. Pillar Invest Corp had sold 2.30M shares worth $4.52M.

Investors sentiment increased to 3.89 in Q4 2017. Its up 2.53, from 1.36 in 2017Q3. It improved, as 5 investors sold Idera Pharmaceuticals, Inc. shares while 13 reduced holdings. 35 funds opened positions while 35 raised stakes. 142.24 million shares or 202.82% more from 46.97 million shares in 2017Q3 were reported. State Of Wisconsin Inv Board owns 79,000 shares. Tudor Inv Corporation Et Al holds 89,256 shares. Badgley Phelps Bell Inc reported 20,000 shares. Balyasny Asset Mngmt Limited Liability Com holds 0% in Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) or 59,416 shares. Ohio-based Meeder Asset Management has invested 0% in Idera Pharmaceuticals, Inc. (NASDAQ:IDRA). 9.01 million were reported by Blackrock Incorporated. Price T Rowe Assocs Md has 38,046 shares. Northern reported 1.62M shares stake. Morgan Stanley holds 0% of its portfolio in Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) for 356,570 shares. Creative Planning stated it has 0% of its portfolio in Idera Pharmaceuticals, Inc. (NASDAQ:IDRA). 46,470 were reported by Prudential Fincl. Royal Natl Bank Of Canada stated it has 13,237 shares. Point72 Asset Lp reported 1.85M shares stake. Amalgamated National Bank & Trust accumulated 19,562 shares or 0% of the stock. Two Sigma Secs Ltd invested in 16,220 shares.

Apple Inc. (NASDAQ:AAPL) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>